Who owns ANAPTYSBIO, INC (ANAB)? Elite investor 13F holders
5 tracked elite investors reported holding ANAPTYSBIO, INC as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Irenic Capital, Gotham Asset Management, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 36427456.00 USD | 539666.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 3935250.00 USD | 58300.000000 | Shares | reduce | Original filing |
| Irenic Capital | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4755173.00 USD | 70447.000000 | Shares | buy | Original filing |
| Gotham Asset Management | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 424710.00 USD | 6292.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 337500.00 USD | 5000.000000 | Shares | buy | Original filing |
| Tudor Investment | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.